The DOI matches its Crossref record; 63 of the 73 references it cites were found in a registry or an index.
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
Open accessAbstract
DNA-damaging agents signal to p53 through as yet unidentified posttranscriptional mechanisms. Here we show that phosphorylation of human p53 at serine 15 occurs after DNA damage and that this leads to reduced interaction of p53 with its negative regulator, the oncoprotein MDM2, in vivo and in vitro. Furthermore, using purified DNA-dependent protein kinase (DNA-PK), we demonstrate that phosphorylation of p53 at serines 15 and 37 impairs the ability of MDM2 to inhibit p53-dependent transactivation. We present evidence that these effects are most likely due to a conformational change induced upon phosphorylation of p53. Our studies provide a plausible mechanism by which the induction of p53 can be modulated by DNA-PK (or other protein kinases with similar specificity) in response to DNA damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [37]
In the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Shieh et al. 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Shieh et al, 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
In the citing paper
“Several landmark studies showed that DNA double strand breaks induce phosphorylation of p53 S15 by DNA-PK and ATM (Mayo et al, 1997;Shieh et al, 1997;Banin et al, 1998;Prives and Hall, 1999).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Self-citationStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Research works printed but not linked: 3
- Hawley, 1996, Stange bedfellows in even stranger places, Genes Dev., 10, 1383
- Meek, 1994, Posttranslational modification of p53, Semin. Cancer Biol., 5, 203
- Nelson, 1994, DNA strand breaks, Mol. Cell. Biol., 14, 1815
Cited by
Sorted by citations
Items 701–800 of 1,005
Novel Functions of the Human Papillomavirus E6 Oncoproteins
Wallace, N. A., & Galloway, D. A. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055021 · Cited by 70
Austin, D. M., Baer, A., Lundberg, L., Shafagati, N., Schoonmaker, A., Narayanan, A., Popova, T., Panthier, J., Kashanchi, F., Bailey, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036327 · Cited by 63
Goudelock, D. M., Jiang, K., Pereira, E., Russell, B., & Sánchez, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301765200 · Cited by 69
Epigenetic regulation of skeletal myogenesis
Saccone, V., & Puri, P. (2010) · Organogenesis · doi:10.4161/org.6.1.11293 · Cited by 67
Xie, X., Li, L., Fan, Y., Lv, L. L., & Zhang, J. (2012) · Autophagy · doi:10.4161/auto.20250 · Cited by 64
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation
Vaganay, S., Muller, C., Marangoni, E., Abdulkarim, B., Deutsch, É., Lambin, P., Calsou, P., Eschwège, F., Salles, B., Joiner, M. C., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1258 · Cited by 63
Crippling p53 activities via knock-in mutations in mouse models
Iwakuma, T., & Lozano, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210278 · Cited by 66
Inhibition of Human p53 Basal Transcription by Down-regulation of Protein Kinase Cδ
Abbas, T., White, D., Li, H., Yoshida, K., Foster, D. A., & Bargonetti, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306979200 · Cited by 63
ING1 and ING2: multifaceted tumor suppressor genes
Guérillon, C., Larrieu, D., & Pedeux, R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1270-z · Cited by 62
Sayed, M., Pelech, S., Wong, C., Marotta, A., & Salh, B. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204894 · Cited by 62
Kumar, P., Coltas, I. K., Kumar, B., Chepeha, D. B., Bradford, C. R., & Polverini, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2265 · Cited by 62
Panagaki, T., Michael, M., & Hölscher, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16488-x · Cited by 63
Bain, P. A., Shaw, G. R., & Patel, B. K. C. (2007) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390701434877 · Cited by 62
hGTSE-1 Expression Stimulates Cytoplasmic Localization of p53
Monte, M., Benetti, R., Collavin, L., Marchionni, L., Sal, G. D., & Schneider, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311123200 · Cited by 62
Ito, K., Nakazato, T., Miyakawa, Y., Yamato, K., Ikeda, Y., & Kizaki, M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10289 · Cited by 62
Solhaug, A., Øvrebø, S., Mollerup, S. K., Låg, M., Schwarze, P. E., Nesnow, S., & Holme, J. A. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.12.002 · Cited by 62
Giono, L. E., & Manfredi, J. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01967-06 · Cited by 62
Buschmann, T., Adler, V., Matusevich, E., Fuchs, S. Y., & Ronai, Z. A. (2000) · PubMed · Cited by 62
P53 and PML: new partners in tumor suppression
Gottifredi, V., & Prives, C. L. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01983-3 · Cited by 62
Self-citationBean, L. J., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204204 · Cited by 63
Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells
Kim, H. J., Vosseler, C. A., Weber, P. C., & Erl, W. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20351 · Cited by 61
Ricciardiello, L., Ceccarelli, C., Angiolini, G., Pariali, M., Chieco, P., Paterini, P., Biasco, G., Martinelli, G. N., Roda, E., & Bazzoli, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0141 · Cited by 61
Intra-S-Phase Checkpoint Activation by Direct CDK2 Inhibition
Zhu, Y., Alvarez, C., Doll, R. J., Kurata, H., Schebye, X. M., Parry, D., & Lees, E. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6268-6277.2004 · Cited by 62
A possible role of p73 on the modulation of p53 level through MDM2.
Wang, X. Q., Ongkeko, W. M., Lau, A. W. S., Leung, K. M., & Poon, R. Y. C. (2001) · PubMed · Cited by 61
DNA Damage Signals Induction of Fas Ligand in Tumor Cells
Mo, Y.-Y., & Beck, W. T. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12017-2 · Cited by 61
Growth arrest in G1 protects against oxygen‐induced DNA damage and cell death
Rancourt, R. C., Hayes, D. D., Chess, P. R., Keng, P. C., & O’Reilly, M. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10146 · Cited by 61
Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation
Ljungman, M. E., O’Hagan, H. M., & Paulsen, M. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204734 · Cited by 62
Thornborrow, E. C., & Manfredi, J. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33747 · Cited by 65
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022) · Oncogene · doi:10.1038/s41388-022-02331-9 · Cited by 60
Coordination of MAPK and p53 dynamics in the cellular responses to DNA damage and oxidative stress
Hanson, R. L., & Batchelor, E. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211401 · Cited by 60
The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage
Wang, H., Zhou, W., Zheng, Z., Zhang, P., Tu, B., He, Q., & Zhu, W. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.014 · Cited by 60
Wang, H., Zhao, Y., Li, L., McNutt, M. A., Wu, L., Lu, S., Yu, Y., Zhou, W., Feng, J., Chai, G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702454200 · Cited by 61
Role of polyamines in p53-dependent apoptosis of intestinal epithelial cells
Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.12.003 · Cited by 61
Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth
Ma, D., Chen, X., Zhang, P.-Y., Zhang, H., Wei, L.-J., Hu, S., Tang, J.-Z., Zhou, M.-T., Xie, C., Ou, R., et al. (2017) · Oncogene · doi:10.1038/onc.2017.398 · Cited by 60
Bokoch, G. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400405 · Cited by 60
Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways
Blaydes, J. P., Craig, A. L., Wallace, M., Ball, H. M.-L., Traynor, N. J., Gibbs, N. K., & Hupp, T. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203773 · Cited by 60
ATM Is Activated in Response toN-Methyl-N′-nitro- N-nitrosoguanidine-induced DNA Alkylation
Adamson, A. W., Kim, W.-J., Shangary, S. K., Baskaran, R., & Brown, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204409200 · Cited by 61
Illuminating p53 function in cancer with genetically engineered mouse models
Garcia, P. B., & Attardi, L. D. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.12.014 · Cited by 65
Activation of ATM and phosphorylation of p53 by heat shock
Miyakoda, M., Suzuki, K., Kodama, S., & Watanabe, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205196 · Cited by 59
Kachnic, L. A., Wu, B., Wunsch, H., Mekeel, K. L., DeFrank, J. S., Tang, W., & Powell, S. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13111 · Cited by 59
Haider, U. G. B., Sorescu, D., Griendling, K. K., Vollmar, A. M., & Dirsch, V. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.925 · Cited by 59
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 59
Abate, G., Frisoni, G. B., Bourdon, J., Piccirella, S., Memo, M., & Uberti, D. L. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00732-0 · Cited by 58
A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer
Satija, Y. K., Bhardwaj, A., & Das, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28129 · Cited by 58
Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
Kitagaki, J., Agama, K., Pommier, Y. G., Yang, Y., & Weissman, A. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0063 · Cited by 58
Lin, C., Mabe, N. W., Lin, Y.-T., Yang, W., Tang, X., Hong, L. T., Sun, T., Force, J. M., Marks, J. R., Yao, T., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0499-y · Cited by 58
Arriola, E. L., Lopez, A. R., & Chresta, C. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202391 · Cited by 58
Multiple ATM-Dependent Pathways: An Explanation for Pleiotropy
Brown, K. D., Barlow, C., & Wynshaw-Boris, A. J. (1999) · The American Journal of Human Genetics · doi:10.1086/302223 · Cited by 58
The end protection problem—an unexpected twist in the tail
Ruis, P., & Boulton, S. J. (2021) · Genes & Development · doi:10.1101/gad.344044.120 · Cited by 57
Mdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57
Lin, T., Mak, N. K., & Yang, M. S. (2008) · Toxicology · doi:10.1016/j.tox.2008.02.017 · Cited by 58
Phelps, M., Phillips, A., Darley, M., & Blaydes, J. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412334200 · Cited by 57
The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis
Schoenfeld, A. R., Parris, T., Eisenberger, A. B., Davidowitz, E. J., Leon, M. D., Talasazan, F., Devarajan, P., & Burk, R. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203985 · Cited by 57
Bishop, A. J. R., Hollander, M. C., Kosaras, B., Sidman, R. L., Fornace, A. J., & Schiestl, R. H. (2003) · PubMed · Cited by 57
Li, J., Zhang, X., Sejas, D. P., & Pang, Q. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.05.005 · Cited by 58
Clonal hematopoiesis and hematological malignancy
Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180065 · Cited by 63
Luciani, M. G., Campregher, C., & Gasché, C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm101 · Cited by 56
Gugliesi, F., Mondini, M., Ravera, R., Robotti, A., Andrea, M. D., Gribaudo, G., Gariglio, M., & Landolfo, S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904507 · Cited by 57
MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation
Jin, Y., Zeng, S. X., Lee, H., & Lu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309916200 · Cited by 56
Splicing DNA-damage responses to tumour cell death
Crighton, D., & Ryan, K. M. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.001 · Cited by 56
Takeba, Y., Kumai, T., Matsumoto, N., Nakaya, S., Tsuzuki, Y., Yanagida, Y., & Kobayashi, S. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070442 · Cited by 57
Drukteinis, J. S., Medrano, T. A., Ablordeppey, E., Kitzman, J. M., & Shiverick, K. T. (2005) · Placenta · doi:10.1016/j.placenta.2005.01.013 · Cited by 56
Delia, D., Panigone, S., Tagliabue, E., Fontanella, E., Pierotti, M. A., Mizutani, S., Asada, M., Yamada, T., Taya, Y., Prudente, S., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1168 · Cited by 59
Self-citationAcute response of human skin to solar radiation: regulation and function of the p53 protein
Decraene, D., Agostinis, P., Pupe, A., Haes, P. D., & Garmyn, M. (2001) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(01)00204-4 · Cited by 56
Arai, S., Matsushita, A., Du, K., Yagi, K., Okazaki, Y., & Kurokawa, R. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.022 · Cited by 55
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer
de Oliveira, G. A. P., Rangel, L. P., da Costa, D. C. F., & Silva, J. L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00097 · Cited by 56
Cadmium Induces Phosphorylation of p53 at Serine 15 in MCF-7 Cells
Matsuoka, M., & Igisu, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4700 · Cited by 55
Nakanishi, M., Ozaki, T., Yamamoto, H., Hanamoto, T., Kikuchi, H., Furuya, K., Asaka, M., Delia, D., & Nakagawara, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611412200 · Cited by 56
Koyano, T., Namba, M., Kobayashi, T., Nakakuni, K., Nakano, D., Fukushima, M., Nishiyama, A., & Matsuyama, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-48557-8 · Cited by 55
Tumor suppressor p53 cross-talks with TRIM family proteins
Liu, J., Zhang, C., Wang, X., Hu, W., & Feng, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.003 · Cited by 57
Batta, K., & Kundu, T. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01064-07 · Cited by 55
Sato, Y., Shirata, N., Kudoh, A., Iwahori, S., Nakayama, S., Murata, T., Isomura, H., Nishiyama, Y., & Tsurumi, T. (2009) · Virology · doi:10.1016/j.virol.2009.03.017 · Cited by 57
Involvement of a p53-Dependent Pathway in Rubella Virus-Induced Apoptosis
Megyeri, K., Berencsi, K., Halazonetis, T. D., Prendergast, G. C., Gri, G., Plotkin, S. A., Rovera, G., & Gönczöl, É. (1999) · Virology · doi:10.1006/viro.1999.9757 · Cited by 55
Martin, M. E. D., & Berk, A. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3403 · Cited by 55
Liu, C., Russell, R. M., & Wang, X. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2705 · Cited by 55
Biochemical and Molecular Mechanisms of Cisplatin Resistance
Siddik, Z. H. (2002) · Cancer treatment and research · doi:10.1007/978-1-4615-1173-1_13 · Cited by 55
Chernov, M. V., Bean, L. J., Lerner, N., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103170200 · Cited by 55
Okada, Y., Osada, M., Kurata, S., Sato, S., Aisaki, K., Kageyama, Y., Kihara, K., Ikawa, Y., & Katoh, I. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5535 · Cited by 55
Cheng, W., Zheng, X., QUIMBY, F. R., Roneker, C. A., & Lei, X. G. (2003) · Biochemical Journal · doi:10.1042/bj20021870 · Cited by 55
Zhang, J., Kan, S., Huang, B., Hao, Z., Mak, T. W., & Zhong, Q. (2011) · Genes & Development · doi:10.1101/gad.170605.111 · Cited by 56
Jowsey, P. A., Williams, F. M., & Blain, P. G. (2008) · Toxicology · doi:10.1016/j.tox.2008.12.001 · Cited by 54
Pirh2 RING‐finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
Jung, Y.-S., Qian, Y., & Chen, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.052 · Cited by 54
Structural and sequential context of p53: A review of experimental and theoretical evidence
Saha, T., Kar, R. K., & Sa, G. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.12.002 · Cited by 58
Wang, X., Zhang, X., Li, P., Liu, Z., Yang, Y., He, Z., Dang, H., & Zhou, S. (2017) · PubMed Central · Cited by 54
Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53
Zhao, Y., Zhang, L., Wu, Y., Dai, Q., Zhou, Y., Li, Z., Yang, L., Guo, Q., & Lu, N. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.011 · Cited by 55
dos Santos, N. M., de Oliveira, G. A. P., Rocha, M. R., Pedrote, M. M., Ferretti, G. D. S., Rangel, L. P., Morgado‐Díaz, J. A., Silva, J. L., & Gimba, E. R. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007566 · Cited by 54
Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression
Yarosh, D. B., Boumakis, S., Brown, A. B., Canning, M. T., Galvin, J. W., Both, D., Kraus, E., O’Connor, A., & Brown, D. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00209-8 · Cited by 54
Activation of DNA damage signaling
Ljungman, M. E. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.02.014 · Cited by 54
Jabbur, J. R., Huang, P., & Zhang, W. (2000) · Oncogene · doi:10.1038/sj.onc.1204017 · Cited by 60
Inoue, T. M., Geyer, R. K., Howard, D., Yu, Z. K., & Maki, C. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107477200 · Cited by 54
A Switch in p53 Dynamics Marks Cells That Escape from DSB-Induced Cell Cycle Arrest
Tsabar, M., Mock, C. S., Venkatachalam, V., Reyes, J. S., Karhohs, K. W., Oliver, T. G., Regev, A., Jambhekar, A., & Lahav, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107995 · Cited by 54
Liang, T., Xie, J., Zhao, J., Huang, W., Xu, Z., Tian, P., Mi, C., Dai, M., Zhang, S., & Zhang, H. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09583-3 · Cited by 53
Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line
Takahashi, K., Tanaka, M., Inagaki, A., Wanibuchi, H., Izumi, Y., MIURA, K., NAGAYAMA, K., Shiota, M., & Iwao, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2135 · Cited by 53
Hayano, S., Komatsu, Y., Pan, H., & Mishina, Y. M. (2015) · Development · doi:10.1242/dev.118802 · Cited by 54
Rodriguez-Enfedaque, A., Bouleau, S., Laurent, M., Courtois, Y., Mignotte, B., Vayssière, J., & Renaud, F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.010 · Cited by 57
Hideshima, T., Cottini, F., Nozawa, Y., Seo, H., Ohguchi, H., Samur, M., Cirstea, D. D., Mimura, N., Iwasawa, Y., Richardson, P. G. G., et al. (2017) · Blood · doi:10.1182/blood-2016-09-738500 · Cited by 56
p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement.
Rödicker, F., & Pützer, B. M. (2003) · PubMed · Cited by 53
Attenuation of the p53 response to DNA damage by high cell density
Bar, J., Cohen-Noyman, E., Geiger, B., & Oren, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207325 · Cited by 53
Zhang, X. H., Zhao, C., Seleznev, K., Song, K., Manfredi, J. J., & Ma, Z. A. (2006) · Journal of Cell Science · doi:10.1242/jcs.02821 · Cited by 53
Metadata
- Authors
- Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C.
- Affiliations
- Columbia University (US)
- Medical & Biological Laboratories (Japan) (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Prives, Carol
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 91
- Issue
- 3
- Pages
- 325-334
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1978518304
- Cited by
- 2,100
- References
- 73
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 40 · 2023: 53 · 2022: 72 · 2021: 53 · 2020: 49 · 2019: 45 · 2018: 47 · 2017: 72 · 2016: 50 · 2015: 55 · 2014: 74 · 2013: 86 · 2012: 84
- FWCI
- 45.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, DNA damage response, DNA-dependent protein kinase, p53-MDM2 interaction, protein conformational change
- MeSH terms
- Binding Sites, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Serine, Tumor Cells, Cultured, Transcriptional Activation, Down-Regulation, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
